Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

Original research

Brothers, Thomas D. et al

Release Date

2022

Geography

Australia

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

Yes

Peer Reviewed

Yes

Objective

Following hospitalization with an injecting-related infection, use of opioid agonist treatment (OAT; methadone or buprenorphine) may be associated with reduced risk of death or rehospitalization with an injecting-related infection.

Findings/Key points

Following hospitalizations with injection drug use–associated bacterial and fungal infections, use of OAT is associated with lower risks of death and recurrent injecting-related infections among people with opioid use disorder.

Design/methods

Data from the Opioid Agonist Treatment Safety (OATS)

doi.org

Keywords

Hospitals

Substitution/OAT

Injecting drugs

Outcomes

About PWUD

Mortality